SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-015572
Filing Date
2024-04-22
Accepted
2024-04-22 17:00:39
Documents
2
Period of Report
2024-04-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 13484
2 ex24.htm EX-24 12095
  Complete submission text file 0001493152-24-015572.txt   27155
Mailing Address C/O DEPOMED, INC. 1360 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Schoeneck James A (Reporting) CIK: 0001420987 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40789 | Film No.: 24861876

Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Issuer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)